Tyler D. Ames

Also affiliated with Io Therapeutics (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “AB016. Phase 2 clinical trial of PT-112 in patients with thymic epithelial tumors”.

AB016. Phase 2 clinical trial of PT-112 in patients with thymic epithelial tumors

Mediastinum(2023)10.21037/med-23-ab016

N/A

0DataRank · unranked

3 citations

Shannon Swift, Renee N. Donahue, Carolina Celades, Yo-Ting Tsai, Molly A. Bingham +14 more

Partial mitochondrial involvement in the antiproliferative and immunostimulatory effects of PT-112

OncoImmunology(2025)10.1080/2162402x.2025.2507245

N/A

0DataRank · unranked

1 citations

Manuel Beltrán‐Visiedo, Ai Sato, Takahiro Yamazaki, Emma Guilbaud, Christina Y. Yim +5 more